Diphtheria-Tetanus-acellular Pertussis Vaccines
"Diphtheria-Tetanus-acellular Pertussis Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Combined vaccines consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and an acellular form of PERTUSSIS VACCINE. At least five different purified antigens of B. pertussis have been used in various combinations in these vaccines.
| Descriptor ID |
D022681
|
| MeSH Number(s) |
D20.215.894.135.535.295 D20.215.894.691.263.290 D20.215.894.691.824.290 D20.215.894.815.149 D20.215.894.860.900.267
|
| Concept/Terms |
Diphtheria-Tetanus-acellular Pertussis Vaccines- Diphtheria-Tetanus-acellular Pertussis Vaccines
- Diphtheria Tetanus acellular Pertussis Vaccines
- Pertussis Vaccines, Diphtheria-Tetanus-acellular
- Vaccines, Diphtheria-Tetanus-acellular Pertussis
- DTaP Vaccines
- Vaccines, DTaP
- DTaP Vaccine
- Vaccine, DTaP
|
Below are MeSH descriptors whose meaning is more general than "Diphtheria-Tetanus-acellular Pertussis Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Diphtheria-Tetanus-acellular Pertussis Vaccines".
This graph shows the total number of publications written about "Diphtheria-Tetanus-acellular Pertussis Vaccines" by people in this website by year, and whether "Diphtheria-Tetanus-acellular Pertussis Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 2 | 4 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diphtheria-Tetanus-acellular Pertussis Vaccines" by people in Profiles.
-
Spatial patterns of HPV and Tdap vaccine dose administration and the association of health department clinic access in Georgia counties. Vaccine. 2022 02 23; 40(9):1352-1360.
-
The impact of provider recommendation on human papillomavirus vaccine and other adolescent vaccines. Hum Vaccin Immunother. 2021 04 03; 17(4):1059-1067.
-
A second dose of a measles-mumps-rubella vaccine administered to healthy four-to-six-year-old children: a phase III, observer-blind, randomized, safety and immunogenicity study comparing GSK MMR and MMR II with and without DTaP-IPV and varicella vaccines co-administration. Hum Vaccin Immunother. 2019; 15(4):786-799.
-
Comparison of adverse events following immunisation with acellular and whole-cell pertussis vaccines: A systematic review. Vaccine. 2018 09 25; 36(40):6007-6016.
-
EDITORIAL. J S C Med Assoc. 2015 Dec-2016 Jan; 111(4):114.
-
Adolescent Vaccination Performance in South Carolina Compared to the United States. J S C Med Assoc. 2015 Dec-2016 Jan; 111(4):117-21.
-
Vaccination Rates among Adolescents in Minnesota as Compared with the United States: Not "Above Average". Minn Med. 2015 Nov-Dec; 98(11-12):38-43.
-
Vaccine hesitancy among parents of adolescents and its association with vaccine uptake. Vaccine. 2015 Mar 30; 33(14):1748-55.
-
Analysis of factors affecting immune recovery and initial response to tetanus after DTaP vaccination in pediatric allogeneic HSCT patients. Pediatr Transplant. 2014 Dec; 18(8):882-8.
-
Adolescent vaccination in Oklahoma: a work in progress. J Okla State Med Assoc. 2014 Sep-Oct; 107(9-10):510-6.